In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Patients undergoing percutaneous coronary interventions who receive high-dose statin treatment before the procedure have about half the rate of major adverse cardiac events…
NEW YORK (Reuters Health) – Stroke patients who receive care in a stroke unit combined with early supported discharge are more likely to be living at home 5…
NEW YORK (Reuters Health) – In a randomized, double-blinded trial of 54 infants with tachypnea, a dose of inhaled salbutamol improved respiratory rate, inspired oxygen, and other measures…
NEW YORK (Reuters Health) – Routine repeat computed tomography (CT) scans aren’t necessary in patients with traumatic head injury who don’t have deteriorating neurological status, concludes a new…
NEW YORK (Reuters Health) – Long-term results confirm that use of neoadjuvant chemotherapy in treating muscle-invasive cancer of the bladder confers a significant survival advantage, an international collaborative…
NEW YORK (Reuters Health) – In surgical patients at high risk of contaminated incisions, a simple protocol of daily wound probing reduces the rate of surgical site infections,…
NEW YORK (Reuters Health) – Vascular complication rates are higher with an antegrade rather than retrograde femoral approach to percutaneous endovascular procedures in the lower extremities, a Michigan…
NEW YORK (Reuters Health) – Ceftazidime and amikacin delivered by nebulizer is as effective as intravenous administration in treating ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, and is…
NEW YORK (Reuters Health) – Contrary to previous findings, patients with advanced cancer do not have significantly improved survival when they are treated with a low-molecular-weight heparin, European…
